Cargando…
Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma
OBJECTIVE: The aim of this study was to evaluate the relation between the rate of fluorine-18 (18F) fludeoxyglucose (FDG) uptake and CD38 and CD138 expression in myeloma cells in bone marrow and other clinical parameters in patients with multiple myeloma (MM). MATERIALS AND METHODS: Patients with th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110447/ https://www.ncbi.nlm.nih.gov/pubmed/29806594 http://dx.doi.org/10.4274/tjh.2017.0372 |
_version_ | 1783350473594503168 |
---|---|
author | Cengiz, Arzu Arda, Hayri Üstün Döğer, Firuzan Yavaşoğlu, İrfan Yürekli, Yakup Bolaman, Ali Zahit |
author_facet | Cengiz, Arzu Arda, Hayri Üstün Döğer, Firuzan Yavaşoğlu, İrfan Yürekli, Yakup Bolaman, Ali Zahit |
author_sort | Cengiz, Arzu |
collection | PubMed |
description | OBJECTIVE: The aim of this study was to evaluate the relation between the rate of fluorine-18 (18F) fludeoxyglucose (FDG) uptake and CD38 and CD138 expression in myeloma cells in bone marrow and other clinical parameters in patients with multiple myeloma (MM). MATERIALS AND METHODS: Patients with the diagnosis of MM who underwent 18F-FDG positron emission tomography/computed tomography (PET/CT) for initial staging were evaluated retrospectively. We analyzed a total of 42 patients (43-83 years old, mean: 64.4±9.9). Hematological and biochemical tests including hemoglobin, hematocrit, C-reactive protein, β2-microglobulin, creatinine, albumin, calcium, lactate dehydrogenase, and erythrocyte sedimentation rate were recorded. In bone marrow samples, plasma cell ratio and CD38 and CD138 immunohistochemical staining were evaluated. On PET/CT images, mean standardized uptake values (SUV(mean)) of the right anterior and posterior iliac crest and right proximal femora were calculated. The correlations between the average SUV(mean) of bone marrow and CD38- and CD138-expressing myeloma cells and other parameters were analyzed by Spearman’s correlation test. Values of p<0.05 were considered statistically significant. RESULTS: Types of MM were IgG(K) (45%), IgG(L) (21%), IgA(K) (7%), IgA(L) (10%), and others (17%). Thirty-two (76%) patients were at stage III according to the Salmon-Durie staging system. There was a statistically significant positive correlation between bone marrow FDG uptake and percentage of plasma cells in bone marrow and CD38 and CD138 expression in plasma cells (r=0.403, r=0.339, and r=0.409) and β2-microglobulin and C-reactive protein levels (r=0.676, r=0.541). There was a negative correlation between bone marrow FDG uptake and hemoglobin and hematocrit values (r=-0.377 and r=-0.368). Other hematological parameters were not correlated with FDG uptake in bone marrow. CONCLUSION: Increased FDG uptake is correlated with the percentage of CD38 and CD138 expression in plasma cells in bone marrow. In addition to initial staging, 18F-FDG PET/CT is useful in treatment planning and prognostic evaluation in MM patients. |
format | Online Article Text |
id | pubmed-6110447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-61104472018-09-01 Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma Cengiz, Arzu Arda, Hayri Üstün Döğer, Firuzan Yavaşoğlu, İrfan Yürekli, Yakup Bolaman, Ali Zahit Turk J Haematol Research Article OBJECTIVE: The aim of this study was to evaluate the relation between the rate of fluorine-18 (18F) fludeoxyglucose (FDG) uptake and CD38 and CD138 expression in myeloma cells in bone marrow and other clinical parameters in patients with multiple myeloma (MM). MATERIALS AND METHODS: Patients with the diagnosis of MM who underwent 18F-FDG positron emission tomography/computed tomography (PET/CT) for initial staging were evaluated retrospectively. We analyzed a total of 42 patients (43-83 years old, mean: 64.4±9.9). Hematological and biochemical tests including hemoglobin, hematocrit, C-reactive protein, β2-microglobulin, creatinine, albumin, calcium, lactate dehydrogenase, and erythrocyte sedimentation rate were recorded. In bone marrow samples, plasma cell ratio and CD38 and CD138 immunohistochemical staining were evaluated. On PET/CT images, mean standardized uptake values (SUV(mean)) of the right anterior and posterior iliac crest and right proximal femora were calculated. The correlations between the average SUV(mean) of bone marrow and CD38- and CD138-expressing myeloma cells and other parameters were analyzed by Spearman’s correlation test. Values of p<0.05 were considered statistically significant. RESULTS: Types of MM were IgG(K) (45%), IgG(L) (21%), IgA(K) (7%), IgA(L) (10%), and others (17%). Thirty-two (76%) patients were at stage III according to the Salmon-Durie staging system. There was a statistically significant positive correlation between bone marrow FDG uptake and percentage of plasma cells in bone marrow and CD38 and CD138 expression in plasma cells (r=0.403, r=0.339, and r=0.409) and β2-microglobulin and C-reactive protein levels (r=0.676, r=0.541). There was a negative correlation between bone marrow FDG uptake and hemoglobin and hematocrit values (r=-0.377 and r=-0.368). Other hematological parameters were not correlated with FDG uptake in bone marrow. CONCLUSION: Increased FDG uptake is correlated with the percentage of CD38 and CD138 expression in plasma cells in bone marrow. In addition to initial staging, 18F-FDG PET/CT is useful in treatment planning and prognostic evaluation in MM patients. Galenos Publishing 2018-09 2018-08-05 /pmc/articles/PMC6110447/ /pubmed/29806594 http://dx.doi.org/10.4274/tjh.2017.0372 Text en © Copyright 2018, Turkish Journal of Hematology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Cengiz, Arzu Arda, Hayri Üstün Döğer, Firuzan Yavaşoğlu, İrfan Yürekli, Yakup Bolaman, Ali Zahit Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma |
title | Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma |
title_full | Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma |
title_fullStr | Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma |
title_full_unstemmed | Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma |
title_short | Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma |
title_sort | correlation between baseline 18f-fdg pet/ct findings and cd38- and cd138-expressing myeloma cells in bone marrow and clinical parameters in patients with multiple myeloma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110447/ https://www.ncbi.nlm.nih.gov/pubmed/29806594 http://dx.doi.org/10.4274/tjh.2017.0372 |
work_keys_str_mv | AT cengizarzu correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma AT ardahayriustun correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma AT dogerfiruzan correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma AT yavasogluirfan correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma AT yurekliyakup correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma AT bolamanalizahit correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma |